Walleye Capital LLC
- SEC CIK
- 0001758720
- Latest filing
- Aug 3, 2026
RIGL holding history
Rigel Pharmaceuticals Inc in every 13F filed by Walleye Capital LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
RIGL overviewAll 13F holders of RIGLFull Q2 2026 holdings
- Shares (Q4 2025)
- 0
- Sold out in Q4 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 0 | $0 | 0.0% | −37,952−100.0% | Sold out | Holders |
| Q3 2025 | 37,952 | $1.08M | <0.1% | +37,952 | New | Holders |
| Q1 2025 | 0 | $0 | 0.0% | −21,621−100.0% | Sold out | Holders |
| Q4 2024 | 21,621 | $363.7K | <0.1% | +21,621 | New | Holders |
| Q2 2022 | 0 | $0 | 0.0% | −1,049,059−100.0% | Sold out | Holders |
| Q1 2022 | 1,049,059 | $3.14M | 0.1% | +319,762+43.8% | Added | Holders |
| Q4 2021 | 729,297 | $1.93M | 0.1% | +729,297 | New | Holders |